Ushering in the Golden Era of Alzheimer Drug Development?

Video

What effect will aducanumab have on Alzheimer disease treatment?

RJ Tesi, MD, discusses the recent aducanumab FDA approval and the implications it will have on the treatment of Alzheimer disease.

Dr Tesi is CEO and Chief Medical Officer of INmuneBio.

Related Videos
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.
Related Content

Sleep Research Roundup: September 29

September 29th 2023

What Will the Future of Alzheimer Disease Treatment Look Like?

July 23rd 2021

Girls and Their Monsters, Part 3

September 18th 2023

The Relevance of New Alzheimer Guidelines for Clinical Practice

August 16th 2012

Girls and Their Monsters, Part 2

September 7th 2023

The Joy of Sailing

September 4th 2023

Sleep Research Roundup: September 29

September 29th 2023

What Will the Future of Alzheimer Disease Treatment Look Like?

July 23rd 2021

Girls and Their Monsters, Part 3

September 18th 2023

The Relevance of New Alzheimer Guidelines for Clinical Practice

August 16th 2012

Girls and Their Monsters, Part 2

September 7th 2023

The Joy of Sailing

September 4th 2023

Sleep Research Roundup: September 29

September 29th 2023

What Will the Future of Alzheimer Disease Treatment Look Like?

July 23rd 2021

Girls and Their Monsters, Part 3

September 18th 2023

The Relevance of New Alzheimer Guidelines for Clinical Practice

August 16th 2012

Girls and Their Monsters, Part 2

September 7th 2023

The Joy of Sailing

September 4th 2023
© 2023 MJH Life Sciences

All rights reserved.